These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 14666323)

  • 21. Association of sweat chloride concentration at time of diagnosis and CFTR genotype with mortality and cystic fibrosis phenotype.
    McKone EF; Velentgas P; Swenson AJ; Goss CH
    J Cyst Fibros; 2015 Sep; 14(5):580-6. PubMed ID: 25660278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis.
    Goubau C; Wilschanski M; Skalická V; Lebecque P; Southern KW; Sermet I; Munck A; Derichs N; Middleton PG; Hjelte L; Padoan R; Vasar M; De Boeck K
    Thorax; 2009 Aug; 64(8):683-91. PubMed ID: 19318346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does integration of various ion channel measurements improve diagnostic performance in cystic fibrosis?
    Ooi CY; Dupuis A; Gonska T; Ellis L; Ni A; Jarvi K; Martin S; Ray P; Steele L; Kortan P; Dorfman R; Solomon M; Zielenski J; Corey M; Tullis E; Durie P
    Ann Am Thorac Soc; 2014 May; 11(4):562-70. PubMed ID: 24697796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of cystic fibrosis in the kindred of an infant with CFTR-related metabolic syndrome: importance of follow-up that includes monitoring sweat chloride concentrations over time.
    Williams SN; Nussbaum E; Chin TW; Do PC; Singh KE; Randhawa I
    Pediatr Pulmonol; 2014 Mar; 49(3):E103-8. PubMed ID: 24535988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Borderline sweat test: Utility and limits of genetic analysis for the diagnosis of cystic fibrosis.
    Seia M; Costantino L; Paracchini V; Porcaro L; Capasso P; Coviello D; Corbetta C; Torresani E; Magazzù D; Consalvo V; Monti A; Costantini D; Colombo C
    Clin Biochem; 2009 May; 42(7-8):611-6. PubMed ID: 19318035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis.
    Farrell PM; Koscik RE
    Pediatrics; 1996 Apr; 97(4):524-8. PubMed ID: 8632940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for cystic fibrosis: the importance of using the correct tools.
    Shah U; Moatter T
    J Ayub Med Coll Abbottabad; 2006; 18(1):7-10. PubMed ID: 16773960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis.
    Mickle JE; Macek M; Fulmer-Smentek SB; Egan MM; Schwiebert E; Guggino W; Moss R; Cutting GR
    Hum Mol Genet; 1998 Apr; 7(4):729-35. PubMed ID: 9499426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystic fibrosis, Young's syndrome, and normal sweat chloride.
    Wellesley D; Schwarz M
    Lancet; 1998 Jul; 352(9121):38. PubMed ID: 9800754
    [No Abstract]   [Full Text] [Related]  

  • 30. Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations.
    Wilschanski M; Zielenski J; Markiewicz D; Tsui LC; Corey M; Levison H; Durie PR
    J Pediatr; 1995 Nov; 127(5):705-10. PubMed ID: 7472820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849 + 10 kb C-->T mutation.
    Augarten A; Kerem BS; Yahav Y; Noiman S; Rivlin Y; Tal A; Blau H; Ben-Tur L; Szeinberg A; Kerem E
    Lancet; 1993 Jul; 342(8862):25-6. PubMed ID: 8100293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of sweat chloride and percent predicted FEV
    Fidler MC; Beusmans J; Panorchan P; Van Goor F
    J Cyst Fibros; 2017 Jan; 16(1):41-44. PubMed ID: 27773592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The significance of sweat Cl/Na ratio in patients with borderline sweat test.
    Augarten A; Hacham S; Kerem E; Sheva Kerem B; Szeinberg A; Laufer J; Doolman R; Altshuler R; Blau H; Bentur L
    Pediatr Pulmonol; 1995 Dec; 20(6):369-71. PubMed ID: 8649916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sweat Chloride Testing.
    McCarthy C; Clancy JP; Brewington J
    JAMA; 2019 Feb; 321(7):701-702. PubMed ID: 30698611
    [No Abstract]   [Full Text] [Related]  

  • 35. Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations.
    Padoan R; Bassotti A; Seia M; Corbetta C
    Eur J Pediatr; 2002 Apr; 161(4):212-5. PubMed ID: 12014388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of cystic fibrosis with chloride meter (Sherwood M926S chloride analyzer®) and sweat test analysis system (CFΔ collection system®) compared to the Gibson Cooke method.
    Emiralioğlu N; Özçelik U; Yalçın E; Doğru D; Kiper N
    Turk J Pediatr; 2016; 58(1):27-33. PubMed ID: 27922233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The predictive potential of the sweat chloride test in cystic fibrosis patients with the G551D mutation.
    Seliger VI; Rodman D; Van Goor F; Schmelz A; Mueller P
    J Cyst Fibros; 2013 Dec; 12(6):706-13. PubMed ID: 23628510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoduct sweat testing for rapid diagnosis in newborns, infants and children with cystic fibrosis.
    Desax MC; Ammann RA; Hammer J; Schoeni MH; Barben J;
    Eur J Pediatr; 2008 Mar; 167(3):299-304. PubMed ID: 17436014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Misdiagnosis of cystic fibrosis based on transient pancreatic insufficiency and elevated sweat chloride.
    Bagheri-Behrouzi A; Steiß JO; Zimmer KP; Nährlich L
    Klin Padiatr; 2015 Mar; 227(2):96-7. PubMed ID: 25751685
    [No Abstract]   [Full Text] [Related]  

  • 40. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
    Sontag MK; Hammond KB; Zielenski J; Wagener JS; Accurso FJ
    J Pediatr; 2005 Sep; 147(3 Suppl):S83-8. PubMed ID: 16202790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.